A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Clinical trial NCT00604123 · COMPLETED
Trial details
- NCT number
- NCT00604123
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-02-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.